1. Guérin, C, Crestani, B, Dupin, C, Kannengiesser, C, Borie, R. 2022. [Telomeres and lung]. In Revue des maladies respiratoires, 39, 595-606. doi:10.1016/j.rmr.2022.03.011. https://pubmed.ncbi.nlm.nih.gov/35715316/
2. Dokal, Inderjeet. . Dyskeratosis congenita. In Hematology. American Society of Hematology. Education Program, 2011, 480-6. doi:10.1182/asheducation-2011.1.480. https://pubmed.ncbi.nlm.nih.gov/22160078/
3. Dou, Jin, Hu, Weikang, Zhang, Xiaoyu, Jiang, Kuirong. 2024. NOP10 predicts poor prognosis and promotes pancreatic cancer progression. In BMC cancer, 24, 1394. doi:10.1186/s12885-024-13180-y. https://pubmed.ncbi.nlm.nih.gov/39538226/
4. Gupta, Vineeta, Kumar, Akash. . Dyskeratosis congenita. In Advances in experimental medicine and biology, 685, 215-9. doi:. https://pubmed.ncbi.nlm.nih.gov/20687509/
5. Elsharawy, Khloud A, Althobiti, Maryam, Mohammed, Omar J, Green, Andrew R, Rakha, Emad A. 2020. Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer. In Breast cancer research and treatment, 185, 615-627. doi:10.1007/s10549-020-05999-3. https://pubmed.ncbi.nlm.nih.gov/33161513/
6. Cui, Chunhong, Liu, Yi, Gerloff, Dennis, Edemir, Bayram, Müller-Tidow, Carsten. 2020. NOP10 predicts lung cancer prognosis and its associated small nucleolar RNAs drive proliferation and migration. In Oncogene, 40, 909-921. doi:10.1038/s41388-020-01570-y. https://pubmed.ncbi.nlm.nih.gov/33288886/